THE Therapeutic Goods Administration has approved Nocdurna (desmopressin), the first and only medication for the treatment of nocturnal polyuria.
Nocdurna, from Ferring Pharmaceuticals, is indicated for the treatment of idiopathic nocturnal polyuria in adults who awaken two or more times each night to void, and have not responded to lifestyle measures.
Go to tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jul 17
